आईएसएसएन:

म्यूकोसल इम्यूनोलॉजी अनुसंधान जर्नल

खुला एक्सेस

हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।

ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं

अमूर्त

Journey Through Mucosal Immunity: Cell Trafficking Tales

Huang Tstein

Mucosal immunity stands as the first line of defense against countless pathogens that attempt to breach the body’s delicate interfaces with the external world. This intricate defense system relies on a sophisticated network of immune cells that constantly patrol the mucosal surfaces, ensuring our protection from infections. At the heart of this defense mechanism lies the fascinating phenomenon of cell trafficking—where immune cells traverse the mucosal tissues, seeking out threats and orchestrating immune responses. This abstract offers a glimpse into the captivating world of mucosal immune cell trafficking. It delves into the journeys undertaken by various immune cell populations, such as T cells, B cells, dendritic cells, and macrophages, as they navigate the mucosal landscapes of the respiratory, gastrointestinal, and genitourinary tracts. These tales of cellular migration involve a delicate balance between chemotaxis, adhesion, and immune activation, all orchestrated to maintain mucosal homeostasis. We explore the factors that influence immune cell recruitment to mucosal sites, including the role of chemokines, adhesion molecules, and the microbiota. Additionally, we discuss the challenges posed by pathogens attempting to subvert the mucosal immune system and how immune cells adapt to these threats. Furthermore, this abstract highlights the clinical relevance of understanding mucosal immune cell trafficking, including its implications for vaccine development, the treatment of mucosal infections, and the management of autoimmune diseases.